Whittier Trust Co. of Nevada Inc. Purchases 348 Shares of Axon Enterprise, Inc $AXON

Whittier Trust Co. of Nevada Inc. grew its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 3.3% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 10,973 shares of the biotechnology company’s stock after purchasing an additional 348 shares during the quarter. Whittier Trust Co. of Nevada Inc.’s holdings in Axon Enterprise were worth $9,085,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Hemington Wealth Management increased its stake in shares of Axon Enterprise by 70.8% in the 2nd quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 17 shares in the last quarter. TCTC Holdings LLC increased its stake in shares of Axon Enterprise by 75.0% in the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock valued at $29,000 after acquiring an additional 24 shares in the last quarter. Bartlett & CO. Wealth Management LLC increased its stake in shares of Axon Enterprise by 132.0% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock valued at $31,000 after acquiring an additional 33 shares in the last quarter. Catalyst Capital Advisors LLC bought a new stake in shares of Axon Enterprise in the 1st quarter valued at $32,000. Finally, Banque Transatlantique SA bought a new stake in shares of Axon Enterprise in the 1st quarter valued at $31,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $683.13 on Tuesday. The firm has a market capitalization of $53.63 billion, a PE ratio of 168.67, a price-to-earnings-growth ratio of 26.04 and a beta of 1.41. The firm has a fifty day simple moving average of $736.73 and a two-hundred day simple moving average of $720.91. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. Axon Enterprise, Inc has a 12 month low of $422.38 and a 12 month high of $885.91.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.58. The business had revenue of $668.54 million during the quarter, compared to analyst estimates of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. Axon Enterprise’s quarterly revenue was up 32.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. Analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. Zacks Research lowered shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 2nd. Craig Hallum upgraded shares of Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 price objective for the company in a research note on Tuesday, August 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of Axon Enterprise in a research note on Wednesday, October 8th. Needham & Company LLC reiterated a “buy” rating and issued a $870.00 price objective on shares of Axon Enterprise in a research note on Wednesday, September 24th. Finally, Piper Sandler initiated coverage on shares of Axon Enterprise in a research note on Tuesday, September 23rd. They issued an “overweight” rating and a $893.00 price objective for the company. Fourteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $841.64.

Insider Activity

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 7,891 shares of Axon Enterprise stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $750.10, for a total transaction of $5,919,039.10. Following the transaction, the insider directly owned 144,538 shares of the company’s stock, valued at $108,417,953.80. The trade was a 5.18% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Monday, August 11th. The stock was sold at an average price of $831.29, for a total transaction of $8,312,900.00. Following the transaction, the chief executive officer directly owned 3,053,982 shares in the company, valued at $2,538,744,696.78. This represents a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 59,932 shares of company stock worth $45,115,616. Company insiders own 5.70% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.